Cargando…
SAT044 Cornus officinalis Decreases Incidence Of Type 1 Diabetes Onset And Hyperglycemia In The Non-obese Diabetic Mouse
Disclosure: J.D. Fletcher: None. G.E. Olsson: None. B.R. Burkhardt: None. Currently, there is only one FDA recently approved interventional agent (teplizumab) that can delay the onset of Type 1 Diabetes (T1D) by slowing the clinical progression of pancreatic β-cell autoimmunity and inhibiting the ev...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555969/ http://dx.doi.org/10.1210/jendso/bvad114.912 |